AbbVie Inc. (NYSE: ABBV) reported fourth quarter 2020 earnings results today.
Worldwide net revenues rose 59.2% year-over-year to $13.8 billion on a reported basis. On an operational basis, sales rose 6.8%.

Net earnings attributable to AbbVie were $36 million, or $0.01 per share, compared to $2.8 billion, or $1.88 per share, last year. The GAAP results included a non-cash charge for Skyrizi contingent consideration revaluation based on higher estimated future sales. Adjusted EPS totaled $2.92.
Both revenue and earnings surpassed market projections.
For the full year of 2021, GAAP EPS is expected to be $6.69-6.89 and adjusted EPS is expected to be $12.32-12.52.
Prior performance

Looking for more insights on the earnings results? Click here to access the full transcripts of the latest earnings conference calls!
Most Popular
Infographic: Key highlights from Best Buy (BBY) Q1 2023 earnings results
Best Buy Co., Inc. (NYSE: BBY) reported first quarter 2023 earnings results today. Enterprise revenue dropped to $10.6 billion from $11.6 billion in the year-ago period. Comparable sales were down
AutoZone (AZO) Q3 Earnings: Key financials and quarterly highlights
AutoZone, Inc. (NYSE: AZO) reported third quarter 2022 earnings results today. Net sales increased 5.9% year-over-year to $3.9 billion. Domestic same-store sales increased 2.6%. Net income decreased 0.6% to $592.6 million, while
Infographic: Zoom Video Communications (ZM) Q1 2023 earnings results
Zoom Video Communications (NASDAQ: ZM) reported lower earnings and higher revenues for the first quarter of 2023. Earnings topped Wall Street's expectations, while revenues matched the estimates. Adjusted earnings, excluding